Recursion Pharmaceuticals, Inc. RXRX
3.88 USD +0.20 (+5.43%)
At closeNov 4, 2026, 7:56 PM EST
3.85 -0.03 -0.77%
After hours · Nov 4, 7:56 PM ET
3.72 Day range 4.01
2.84 52-week range 5.00
- YTD
- -5.13%
- 1 year
- -22.40%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 74.68M | 58.84M | 44.58M | 39.84M | 10.18M | |
| 3.73M | 13.60M | 1.99M | -8.43M | 10.18M | |
| -648.13M | -479.00M | -350.06M | -245.73M | -182.78M | |
| -644.76M | -463.66M | -328.07M | -239.48M | -186.48M | |
| -1.44 | -1.69 | -1.58 | -1.36 | -1.49 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 747.89M | 597.39M | 394.80M | 551.19M | 286.67M | |
| 1.47B | 1.45B | 653.70M | 701.29M | 610.35M | |
| 343.26M | 413.82M | 190.26M | 215.48M | 67.41M | |
| 77.97M | 108.49M | 50.67M | 51.01M | 10.06M | |
| 1.13B | 1.03B | 463.44M | 485.81M | 542.94M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -371.81M | -359.17M | -287.78M | -83.52M | -158.61M | |
| -16.87M | 260.06M | -10.23M | 193.25M | -271.74M | |
| 521.53M | 304.12M | 140.13M | 154.34M | 458.54M | |
| -6.47M | -13.70M | -11.96M | -37.06M | -39.80M | |
| 150.90M | 201.60M | -157.69M | 263.76M | 28.18M |